www.advansiv.net Open in urlscan Pro
2a02:26f0:64::210:6ad1  Public Scan

Submitted URL: https://rs.amerisourcebergen.advansiv.com/clk?params=GM4DEMRVGIYTAOJUHE4ACMJRGU4AC2DUORYDULZPO53XOLTBMR3GC3TTNF3C43TFOQXWG3DJMVXHI4ZPMFRGG...
Effective URL: http://www.advansiv.net/clients/abc/HTML/2023/2023-04-ABC-New-Product-Launch-BACLOFEN-ORAL-SUS.htm?rs_oid_rd=382252109498
Submission: On April 24 via api from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

New Product launch April 21, 2023

BACLOFEN ORAL SUS

Supplier: Wilshire Pronunciation: BAK-loe-fen Compared to: Fleqsuvy Rating: ZC
Therapeutic class: Muscle Relaxants Exclusivity: No Authorized generic: Yes
First to Shelf® auto-shipment: No 45-day brand to generic substitution: No
Expected in distribution centers: 04/21/2023

Please check your ordering system for pricing information.



ABC 8 NDC Description 10278699 52536060011 BACLOFEN 25MG/5ML ORAL SUS 120 ML
10278812 52536060012 BACLOFEN 25MG/5ML ORAL SUS 300 ML


AmerisourceBergen continually adds newly launched generics to the PRxO Generics
formulary. All PRxO Generics purchases count towards PRxO Generics compliance
and a majority of these purchases are eligible for PRxO Generics rebates. To
determine if a specific item is rebate eligible, please reference your PRxO
Generics contract in your ordering system. Non-rebatable items are priced to
provide you with meaningful on-invoice savings.

1. Confidential & proprietary information of AmerisourceBergen Corporation. 2.
Marks referenced herein may belong to entities other than AmerisourceBergen and
may be registered or otherwise protected. 3. Comparisons are based on FDA
determinations.



The AmerisourceBergen® logo, AmerisourceBergen® and PRxO Generics® First to
Shelf® are registered trademarks. Information contained in this document is
based on currently available manufacturer information and is subject to change
at any time based on market changes.

This email was sent by:
AmerisourceBergen
1300 Morris Drive, Chesterbrook, PA 19087
610.727.7000
http://www.amerisourcebergen.com

© 2023 AmerisourceBergen Corporation. All Rights Reserved.